Afferent Pharmaceuticals

First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Afferent Pharmaceuticals plus 5456 other startups.